ArticleCritical care (London, England)2021

Letter on "(1,3)-β-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial".

Antonios Kritikos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.